ACH ACCENDRA HEALTH INC revenue, earnings and financials

For the quarter ended June 30, 2026, ACCENDRA HEALTH INC reported revenue of $613M (down 10.1% from a year earlier), net income of −$89.1M and diluted EPS of −$1.16; over the last four quarters revenue was $2.65B and net income −$302M; for the fiscal year ended December 2025 revenue was $2.76B, up 3.1% on the year before.

ACH annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $2.76B, gross profit n/a, operating income $27.5M, net income −$1.10B (margin -39.8%), EPS −$14.31
• Fiscal year ended Dec 2024: revenue $2.68B, gross profit $2.22B, operating income −$218M, net income −$363M (margin -13.5%), EPS −$4.73
• Fiscal year ended Dec 2023: revenue $2.55B, gross profit $2.13B, operating income $133M, net income −$41.3M (margin -1.6%), EPS −$0.53
• Fiscal year ended Dec 2022: revenue $9.96B, gross profit $1.83B, operating income $143M, net income $22.4M (margin 0.2%), EPS $0.29
• Fiscal year ended Dec 2021: revenue $9.79B, gross profit $1.51B, operating income $368M, net income $222M (margin 2.3%), EPS $2.94

ACH quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $613M (down 10.1% year over year), net income −$89.1M, EPS −$1.16
• Quarter ended Mar 31, 2026: revenue $628M (down 6.8% year over year), net income −$6.47M, EPS −$0.08
• Quarter ended Dec 31, 2025 (from the annual report): revenue $709M (up 155.4% year over year), net income −$56.3M, EPS −$0.75
• Quarter ended Sep 30, 2025: revenue $697M (up 1.5% year over year), net income −$150M, EPS −$1.94
• Quarter ended Jun 30, 2025: revenue $682M (up 3.3% year over year), net income −$869M, EPS −$11.30
• Quarter ended Mar 31, 2025: revenue $674M (down 74.2% year over year), net income −$25.0M, EPS −$0.32
• Quarter ended Dec 31, 2024 (from the annual report): revenue −$1.28B (up 75.0% year over year), net income −$296M, EPS −$3.86
• Quarter ended Sep 30, 2024: revenue $687M (down 73.5% year over year), net income −$12.8M, EPS −$0.16
• Quarter ended Jun 30, 2024: revenue $660M (down 74.2% year over year), net income −$31.9M, EPS −$0.42
• Quarter ended Mar 31, 2024: revenue $2.61B (up 3.6% year over year), net income −$21.9M, EPS −$0.29
• Quarter ended Dec 31, 2023 (from the annual report): revenue −$5.13B (down 300.9% year over year), net income $17.8M, EPS $0.24
• Quarter ended Sep 30, 2023: revenue $2.59B (up 3.8% year over year), net income −$6.43M, EPS −$0.08
• Quarter ended Jun 30, 2023: revenue $2.56B (up 2.5% year over year), net income −$28.2M, EPS −$0.37
• Quarter ended Mar 31, 2023: revenue $2.52B (up 4.8% year over year), net income −$24.4M, EPS −$0.32
• Quarter ended Dec 31, 2022 (from the annual report): revenue $2.55B (up 3.4% year over year), net income −$58.0M, EPS −$0.76
• Quarter ended Sep 30, 2022: revenue $2.50B (down 0.2% year over year), net income $12.5M, EPS $0.16
• Quarter ended Jun 30, 2022: revenue $2.50B (up 0.4% year over year), net income $28.6M, EPS $0.37
• Quarter ended Mar 31, 2022: revenue $2.41B (up 3.5% year over year), net income $39.3M, EPS $0.52
• Quarter ended Dec 31, 2021 (from the annual report): revenue $2.47B, net income $42.0M, EPS $0.51
• Quarter ended Sep 30, 2021: revenue $2.50B, net income $44.1M, EPS $0.58

ACH cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow n/a, share buybacks $10.2M
• Fiscal year ended Dec 2024: operating cash flow $161M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $741M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow $325M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow $124M, share buybacks n/a, dividends $0.01 per share

ACH balance sheet

• Jun 30, 2026: cash $7.65M, total assets $2.11B, total liabilities $2.66B, shareholders' equity −$551M
• Mar 31, 2026: cash $337M, total assets $2.42B, total liabilities $2.88B, shareholders' equity −$465M
• Dec 31, 2025: cash $282M, total assets $2.45B, total liabilities $2.91B, shareholders' equity −$461M
• Sep 30, 2025: cash $32.8M, total assets $4.04B, total liabilities $4.47B, shareholders' equity −$430M
• Jun 30, 2025: cash $38.3M, total assets $4.15B, total liabilities $4.44B, shareholders' equity −$281M
• Mar 31, 2025: cash $59.4M, total assets $4.86B, total liabilities $4.29B, shareholders' equity $571M
• Dec 31, 2024: cash $27.6M, total assets $4.66B, total liabilities $4.07B, shareholders' equity $586M
• Sep 30, 2024: cash $45.5M, total assets $5.08B, total liabilities $4.21B, shareholders' equity $896M

What is ACH's revenue?

ACCENDRA HEALTH INC reported $2.65B of revenue over its last four quarters, through June 30, 2026.

Is ACH profitable?

No. ACCENDRA HEALTH INC lost $302M over the last four quarters.

What is ACH's EPS?

Diluted earnings per share over the last four quarters were −$3.93; −$1.16 in the latest quarter.

Does ACH pay a dividend?

ACCENDRA HEALTH INC paid $0.01 per share in dividends in the fiscal year ended December 2021.

ACH ownership and insider trades · All stocks